Robert BraithwaiteCEO at Luqa Pharmaceuticals
Mr. Robert Braithwaite co-founded Luqa Pharmaceuticals
and has served as Chief Executive Officer and a member of the board of
directors since its inception in June 2010. Luqa is a leading
China-focused specialty care company with a strong commercial
business in China, a leading position in dermatology and aesthetics market
and a deep pipeline of innovative products. The company's mission is to
provide healthcare products and solutions for a better life. The
company has to date raised over US$ 30 million in funding
from leading China investors like Morningside Ventures and Cenova Capital,
Delos Capital and family offices.
Robert has been in China since 2005. He initially built Almirall’s commercial presence in the country. He also led all commercial and corporate development roles in APAC markets. Earlier in career, Robert was also responsible for Almirall's operations in Central and Eastern Europe, Middle East and Africa. Before Almirall, Robert was at Alcon where he worked in the surgical team in a financial controlling role. He also managed Alcon’s businesses in Africa and the Middle East. Robert is fluent in English, Spanish and Catalan and conversational in Mandarin. He is a UK national educated in both UK and Spain.